Marlborough medical device company CardioFocus announced on Monday that it has expanded sales to Spain and Portugal.
The sales will expand through its existing French distribution partnership agreement with MicroPort CRM. The firm makes products to help treat irregular heartbeats.
“Based on the success in France, we believe MicroPort will achieve rapid HeartLight X3 adoption in both Spain and Portugal,” Burke T. Barrett, CEO and president of CardioFocus, said in a release.
The HeartLight X3 System received European CE Mark approval in 2019.
